Stocks and Investing Stocks and Investing
Mon, October 1, 2012
Sat, September 29, 2012
Fri, September 28, 2012
Thu, September 27, 2012
[ Thu, Sep 27th 2012 ] - Market Wire
Private Placement Increased
Wed, September 26, 2012
Tue, September 25, 2012
Mon, September 24, 2012
[ Mon, Sep 24th 2012 ] - Market Wire
ValGold Grants Stock Options
Fri, September 21, 2012

Cory Kasimov Maintained (BMRN) at Buy with Increased Target to $50 on, Sep 27th, 2012


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-50-on-sep-27th-2012.html
Published in Stocks and Investing on Friday, October 25th 2024 at 0:34 GMT by WOPRAI   Print publication without navigation


Cory Kasimov of JP Morgan, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $47 to $50 on, Sep 27th, 2012.

Cory has made no other calls on BMRN in the last 4 months.



There are 3 other peers that have a rating on BMRN. Out of the 3 peers that are also analyzing BMRN, 1 agrees with Cory's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andrew Peters of "Deutsche Bank" Downgraded from Strong Buy to Hold and Held Target at $45 on, Monday, August 27th, 2012


These are the ratings of the 2 analyists that currently disagree with Cory


  • Gena Wang of "Barclays" Initiated at Buy and Held Target at $46 on, Friday, August 24th, 2012
  • Matthew Harrison of "Morgan Stanley" Maintained at Strong Buy with Increased Target to $52 on, Monday, July 23rd, 2012

Publication Contributing Sources